SURENDRA K AJJARAPU

CIK 1368298 · Chairman and CEO · last filed 2026-04-23

SURENDRA K AJJARAPU is a Chairman and CEO who has filed 19 SEC Form 4 insider transactions across 5 companies since 2020. The most recent filing shows the insider was granted $1.0M of WGRX on Apr 23, 2026. Across all open-market trades the lifetime net is +$130.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $43.0M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$42.96M

Companies

5

Total Filings

19

Lifetime Open-Market Net

$130.01M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
WGRX Director 12,345,447 $3.48 $42.96M $0 2 2026-04-23
Scienture Holdings, Inc. (MEDS) Delisted Chairman and CEO 117,487 $7.59 $891.7K $130.01M 7 2024-05-28
Tevogen Bio Holdings Inc. (LGSTW) Delisted CEO and Chairman 8,988,889 $0.06 $540.2K $0 2 2023-06-21
Ocean Biomedical, Inc. (OCEAW) Delisted Director 258,200 $0.03 $7.7K $0 2 2023-03-24
Ocean Biomedical, Inc. (AEHAW) Delisted Chief Executive Officer $0.16 $0 1 2021-12-16

Recent Filings

19 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-04-23 WGRX Grant (A) +5,000,000 $1.00M EDGAR
2025-03-25 WGRX Grant (A) +4,082,247 $0 EDGAR
2024-05-28 Scienture Holdings, Inc. (MEDS) Delisted Grant (A) +10,000 $0 EDGAR
2024-01-16 Scienture Holdings, Inc. (MEDS) Delisted Grant (A) +150,000 $0 EDGAR
2023-06-21 Tevogen Bio Holdings Inc. (LGSTW) Delisted Grant (A) +7,988,889 $0 EDGAR
2023-06-12 Tevogen Bio Holdings Inc. (LGSTW) Delisted Grant (A) +1,000,000 $0 EDGAR
2023-03-24 Ocean Biomedical, Inc. (OCEAW) Delisted Other (J) −1,050,000 $0 EDGAR
2023-03-02 Ocean Biomedical, Inc. (OCEAW) Delisted Mixed −3,795,000 $0 EDGAR
2022-09-16 Scienture Holdings, Inc. (MEDS) Delisted Grant (A) +51,724 $0 EDGAR
2022-05-23 Scienture Holdings, Inc. (MEDS) Delisted Buy (P) +10,000 $130.00M EDGAR
Showing 110 of 19
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.